F Fuzkk Atlas of Asia, the Middle East, Canada, Australia and Africa
#121Extended selection 101–300

HanAll Biopharma

South Korea · East Asia

Biologics

Manufacturing profile

Biologics

Country: South Korea

Macro-region: East Asia

Selection basis

The company is placed in positions 101–300 as a manufacturer, biotech, specialty-pharma, generics or CDMO company with practical relevance to the existing FUZKK catalog.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Representative manufacturing and QC chain

  1. 1Cell bank or microbial seed
  2. 2Upstream culture or fermentation
  3. 3Clarification and chromatography
  4. 4UF/DF, formulation and sterile filtration
  5. 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC

Relevant FUZKK packages

South Korea: national essential medicines QC packageGlobal API & Biosimilars QC SuiteLabEx QC Suite

Product/API utilities

Residual Host Cell DNA Quality CheckerResidual Host Protein Checker

Lumex — instrumental QC

CE Glycosylation Profiler

LabEx — laboratory QC

Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality Checker

Medical Devices — equipment and software lifecycle

Supplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Methodology